{{Rsnum
|rsid=11942223
|Gene=SLC2A9
|Chromosome=4
|position=9961141
|Orientation=plus
|GMAF=0.2195
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC2A9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.5 | 47.7 | 50.8
| HCB | 0.0 | 2.2 | 97.8
| JPT | 0.0 | 2.2 | 97.8
| YRI | 11.1 | 50.8 | 38.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 2.2 | 97.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19877038
|Title=Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand M&#x101;ori, Pacific Island, and Caucasian case-control sample sets
}}

{{PMID Auto
|PMID=23349133
|Title=Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}